Evaluation of TaiHao Breast Ultrasound Diagnosis Software

Sponsor
TaiHao Medical Inc. (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT04551105
Collaborator
Columbia University (Other), Taipei Veterans General Hospital, Taiwan (Other), Virginia Polytechnic Institute and State University (Other)
16
1
4
2.5
6.4

Study Details

Study Description

Brief Summary

The BR-USCAD DS Module is a computer-assisted detection and diagnosis software based on a deep learning algorithm. This retrospective, fully-crossed, multi-reader, multi-case (MRMC) study aims to compare the performances of readers without and with the aid of the Breast Ultrasound Image Reviewed with Assistance of Computer-Assisted Detection and Diagnosis System (BR-USCAD DS) in interpreting breast ultrasound images of lesions.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Reader Group X
  • Diagnostic Test: Reader Group Y
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Evaluation of TaiHao Breast Ultrasound Diagnosis Software
Actual Study Start Date :
Aug 15, 2020
Anticipated Primary Completion Date :
Sep 30, 2020
Anticipated Study Completion Date :
Oct 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: First session: manual review first and then review with CADx

Each rater will interpret the "Dataset A" cases in different random order without any assistance of artificial assistance first, and then interpret the "Dataset B" cases in different random order with BR-USCAD DS.

Diagnostic Test: Reader Group X
Each rater in "Reader Group X" will interpret the "dataset A" cases in different random order without BR-USCAD DS and interpret the "dataset B" cases in different random order with BR-USCAD DS.

Active Comparator: First session: review with CADx first and then manual review

Each rater will interpret the "Dataset A" cases in different random order with BR-USCAD DS first, and then interpret the "Dataset B" cases in different random order without any assistance of artificial assistance.

Diagnostic Test: Reader Group Y
Each rater in "Reader Group Y" will interpret the "dataset A" cases in different random order with BR-USCAD DS and interpret the "dataset B" cases in different random order without BR-USCAD DS.

Active Comparator: Second session: manual review first and then review with CADx

At least 4 weeks after first session for memory washing out. Each rater will interpret the "Dataset A" cases in different random order without any assistance of artificial assistance first, and then interpret the "Dataset B" cases in different random order with BR-USCAD DS.

Diagnostic Test: Reader Group Y
Each rater in "Reader Group Y" will interpret the "dataset A" cases in different random order with BR-USCAD DS and interpret the "dataset B" cases in different random order without BR-USCAD DS.

Active Comparator: Second session: review with CADx first and then manual review

At least 4 weeks after first session for memory washing out. Each rater will interpret the "Dataset A" cases in different random order with BR-USCAD DS first, and then interpret the "Dataset B" cases in different random order without any assistance of artificial assistance.

Diagnostic Test: Reader Group X
Each rater in "Reader Group X" will interpret the "dataset A" cases in different random order without BR-USCAD DS and interpret the "dataset B" cases in different random order with BR-USCAD DS.

Outcome Measures

Primary Outcome Measures

  1. MRMC AUC analysis [15 Day]

    Area under the ROC curve. Value range: [0, 1]

Secondary Outcome Measures

  1. Sensitivity [2 Days]

    Sensitivity = TP/P, value range: [0, 1] Comparing to the reference standard, the sensitivity of breast imaging results by readers with BR-USCAD DS will be evaluated.

  2. Specificity [2 Days]

    Specificity = TN/N, value range: [0, 1] Comparing to the reference standard, the specificity of breast imaging results by readers with BR-USCAD DS will be evaluated.

  3. Inter-rater reliability [2 Days]

    Calculate Kappa result to evaluate the agreement between raters and system. The Kappa value could be interpreted as follows: values ≤ 0 as indicating no agreement and 0.01-0.20 as none to slight, 0.21-0.40 as fair, 0.41- 0.60 as moderate, 0.61-0.80 as substantial, and 0.81-1.00 as almost perfect agreement.

  4. Reading time [2 Days]

    Reading time in seconds. Measure reading time of breast imaging reporting and system lexicon value in breast imaging by readers without BR-USCAD DS for breast and also measured report time by readers with BR-USCAD DS for breast.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • B-mode breast ultrasound image

  • Female, age 21 or older

  • Breast lesion images acquired before a biopsy or surgery - these images were retrospectively collected with histology report.

  • Non-biopsied benign lesions with negative follow-up for a minimum of 12 months

  • At least two orthogonal views of a lesion

  • All the cases in this study are collected from at least 3 different ultrasound apparatuses

Exclusion Criteria:
  • Breast lesion images acquired after biopsy or surgery.

  • Any breast surgeries or interventional procedures in the 12 months prior to ultrasound imaging

  • Case demonstrating administrative or technical errors

  • Multiple lesions in one 2-D ultrasound image

  • Breast ultrasound images with Doppler, elastography, or other overlays present

Contacts and Locations

Locations

Site City State Country Postal Code
1 Arlington Innovation Center: Health Research - Virginia Tech Arlington Virginia United States 22203

Sponsors and Collaborators

  • TaiHao Medical Inc.
  • Columbia University
  • Taipei Veterans General Hospital, Taiwan
  • Virginia Polytechnic Institute and State University

Investigators

  • Study Director: Shih Chung Lo, Ph.D., Arlington Innovation Center: Health Research - Virginia Tech

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
TaiHao Medical Inc.
ClinicalTrials.gov Identifier:
NCT04551105
Other Study ID Numbers:
  • TaiHao BR-USCAD VT 20-249
First Posted:
Sep 16, 2020
Last Update Posted:
Sep 16, 2020
Last Verified:
Sep 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2020